269 results on '"Comanor, William S."'
Search Results
52. Is there a consensus on the antitrust treatment of single-firm conduct?
53. Leegin and its progeny: implications for Internet commerce.
54. The costs of regulation: branded open supply and uniform pricing of gasoline
55. The Antitrust Revolution
56. The Economics of Research and Development in the Pharmaceutical Industry
57. Competition Policy in the Global Economy
58. Antitrust policy toward resale price maintenance following Leegin.
59. Competition Policy towards Vertical Restraints in Europe and the United States
60. Child support payments: a review of current policies
61. Our Separate Ways: The Struggle for the Future of the U.S.-Israel Alliance
62. Child visitation and performance: the evidence.
63. Market power or efficiency: A review of antitrust standards
64. Steiner's two-stage vision: implications for antitrust analysis.
65. On Advertising and Profitability
66. The two economics of vertical restraints
67. The two economics of vertical restraints.
68. 'Brief for 27 Antitrust Scholars as Amici Curiae in Support of Neither Party,' United States Of America, Plaintiff-Appellant, v. AT&T Inc.; Directv Group Holdings, LLC; And Time Warner Inc., Defendants-Appellees. On Appeal from the United States District Court for the District of Columbia, No. 1:17-cv-2511 (Hon. Richard J. Leon). United States Court of Appeals for the District of Columbia Circuit
69. U.S. Pharmaceutical Markets: Expenditures, Health Insurance, New Products and Generic Prescribing from 1960 to 2016
70. Global Issues on Competition Policy: Introduction
71. Competition policy towards vertical foreclosure in a global economy.
72. Predatory pricing and the meaning of intent.
73. A U.S. Antitrust Agenda for the Dominant Information Platforms.
74. U.S. Pharmaceutical Markets: Expenditures, Health Insurance, New Products and Generic Prescribing from 1960 to 2016.
75. Industrial Efficiency in Six Nations
76. Studies in Economic Rationality: X-Efficiency Examined and Extolled: Essays Written in the Tradition of and to Honor Harvey Liebenstein
77. Knights, Raiders, and Targets: the Impact of the Hostile Takeover
78. The problem of remedy in monopolization cases: the Microsoft case as an example.
79. Mergers and Innovation in the Pharmaceutical Market
80. Pharmaceutical Economics Since the 1960s: Plus Ça Change, Plus C’est La Même Chose
81. On The Economics of Advertising: A Reply to Bloch and Simon
82. Handbook of the Law of Antitrust Lawrence A. Sullivan
83. VERTICAL MERGERS AND MARKET FORECLOSURE
84. Pharmaceutical economics
85. Antitrust policy and strategic behavior
86. Vertical arrangements and antitrust analysis.
87. The role of the Federal Trade Commission.
88. The Impact of Income and Family Structure on Delinquency
89. Pharmaceutical Economics
90. Mergers and Innovation in the Pharmaceutical Industry
91. Prices Of Pharmaceuticals In Poor Countries Are Much Lower Than In Wealthy Countries
92. Antitrust enforcement policies towards vertical restraints.
93. The international supply of medicines.
94. Antitrust in a political environment.
95. The Lost Generation: A Correction
96. Advertising and Steiner’s Dual Stage Model: Our Assessment
97. Vertical Antitrust Policy as a Problem of Inference: The Response of the American Antitrust Institute
98. HMOs Do What They Were Designed to Do -- Cut Costs / We can't have more than we can pay for but we can choose to pay more
99. Steiner s Two-Stage Vision: Implications for Antitrust Analysis
100. Pharmaceutical Innovation: Revolutionizing Human Health Ralph Landau Basil Achilladelis Alexander Scriabine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.